BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9654650)

  • 1. C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors.
    Ganeshapillai D; Woo LWL; Thomas MP; Purohit A; Potter BVL
    ACS Omega; 2018 Sep; 3(9):10748-10772. PubMed ID: 30320251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Difluoromethoxy-Substituted Estratriene Sulfamates: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Steroid Sulfatase Inhibition.
    Dohle W; Asiki H; Gruchot W; Foster PA; Sahota HK; Bai R; Christensen KE; Hamel E; Potter BVL
    ChemMedChem; 2022 Dec; 17(23):e202200408. PubMed ID: 36109340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.
    Chiu PF; Lin IC; Lu YL; Chang CN; Chan HY; Lin TS; Tsai KC; Hsieh YSY; Chen MJ; Lin MH; Liang PH
    Bioorg Chem; 2023 Sep; 138():106581. PubMed ID: 37172437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
    Thomas MP; Potter BV
    J Med Chem; 2015 Oct; 58(19):7634-58. PubMed ID: 25992880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of biphenyl and biphenyl ether inhibitors of sulfatases.
    Reuillon T; Alhasan SF; Beale GS; Bertoli A; Brennan A; Cano C; Reeves HL; Newell DR; Golding BT; Miller DC; Griffin RJ
    Chem Sci; 2016 Apr; 7(4):2821-2826. PubMed ID: 28660059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative and Antimetastatic Properties of 16-Azidomethyl Substituted 3-
    Senobar Tahaei SA; Kulmány Á; Minorics R; Kiss A; Szabó Z; Germán P; Szebeni GJ; Gémes N; Mernyák E; Zupkó I
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid dual aromatase-steroid sulfatase inhibitors with exquisite picomolar inhibitory activity.
    Woo LW; Bubert C; Purohit A; Potter BV
    ACS Med Chem Lett; 2011 Mar; 2(3):243-7. PubMed ID: 24900302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Discovery of Estra-1,3,5(10),6,8-pentaene-2,16α-diol.
    Wai H; Du K; Anesini J; Kim WS; Eastman A; Micalizio GC
    Org Lett; 2018 Oct; 20(19):6220-6224. PubMed ID: 30221523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid Sulphatase and Its Inhibitors: Past, Present, and Future.
    Foster PA
    Molecules; 2021 May; 26(10):. PubMed ID: 34064842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells.
    Shafiee F; Sadeghi-Aliabadi H; Hassanzadeh F
    Adv Biomed Res; 2012; 1():76. PubMed ID: 23326806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
    Ahmed S; Owen CP; James K; Sampson L; Patel CK
    Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of potent non-estrogenic estrone sulfatase inhibitors.
    Li PK; Chu GH; Guo JP; Peters A; Selcer KW
    Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
    Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.